Search Results - "Garibaldi C"

Un piccolo contributo alla teoria degli aggregati.

Authors: Garibaldi, C.¹

Source: Rendiconti del Circolo Matematico di Palermo (Series 2). Jan1960, Vol. 9 Issue 1, p198-201. 4p.

The virtual oil company.

Authors: Garibaldi, C. A. Haney, R. M. Ross, C. E.

Source: Journal of Petroleum Technology; September 1995, Vol. 47, p776-781, 6p

Earthquake-triggered deposits in the subduction trench of the north Ecuador/south Colombia margin and their implication for paleoseismology.

Authors: Migeon, S. Garibaldi, C. Ratzov, G. et al.

Source: Marine Geology. Feb2017, Vol. 384, p47-62. 16p.

Subjects: Earthquakes, Subduction, Turbidites, Paleoseismology, Ferromagnetism

SP-0374 Full integration in the curriculum: this should match our teaching / understanding of radiation interaction with matter.

Authors: Garibaldi, C. (AUTHOR)

Source: Radiotherapy & Oncology. 2022 Supplement 1, Vol. 170, pS311-S312. 2p.

Subjects: Radiation, Curriculum

SP-0032: Transforming CTV definition from an art to science.

Authors: Bortfeld, T. Garibaldi, C.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS7-S8. 2p.

Subjects: Medical physics, Definitions

Extracranial frameless stereotactic radiosurgery with multi-modal imaging and opto-electronic position verification

Authors: Riboldi, M. Garibaldi, C. Baroni, G. et al.

Source: International Congress Series. Jul2004, Vol. 1268, p318-322. 5p.

EP-1822 Evaluation of plan robustness against tumor motion for lung SBRT treatment with non-coplanar VMAT.

Authors: Garibaldi, C. Bazani, A. Pansini, F. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS988-S989. 2p.

Subjects: Therapeutics, Lung cancer

Interim 18F-FDG Positron Emission Tomography/Computed Tomography During Chemoradiotherapy in the Management of Cancer Patients.

Authors: Garibaldi, C. Ferrari, M. Grana, C.M. et al.

Source: Clinical Oncology. Apr2019, Vol. 31 Issue 4, p267-268. 2p.

EP-1082: Interim 18F-FDG-PET/CT during chemoradiotherapy for early outcome prediction of head and neck cancer.

Authors: Garibaldi, C. Ronchi, S. Cremonesi, M. et al.

Source: Radiotherapy & Oncology. Apr2016 Supplement 1, Vol. 119, pS520-S520. 1p.

Subjects: Head & neck cancer treatment, Fluorodeoxyglucose F18, Positron emission tomography, Chemoradiotherapy, Medical care

PO-1064: 90y/ 177Lu-radiopeptide therapy and external beam radiation therapy applied to neuroendocrine tumor patients.

Authors: Cremonesi, M. Garibaldi, C. Ferrari, M. et al.

Source: Radiotherapy & Oncology. 2014 Supplement, Vol. 115, pS573-S574. 1p.

Subjects: Peptide analysis, Lutetium, Cancer radiotherapy, Neuroendocrine tumors, Cancer patients

PO-0848: Image-guided lung stereotactic treatments with the vero system.

Authors: Garibaldi, C. Ferrari, A.M. Comi, S. et al.

Source: Radiotherapy & Oncology. Mar2013 Supplement 2, Vol. 106, pS326-S326. 1p.

Subjects: Image-guided radiation therapy, Stereotactic radiotherapy, Lung cancer treatment, Cancer radiotherapy, Publishing

EP-1110 DOES THE TREATED VOLUME HAVE AN IMPACT ON SET-UP ERRORS IN THE RAPIDARCTM TREATMENT OF PROSTATE CARCINOMA?

Authors: Garibaldi, C. Jereczek-Fossa, B.A. Zerini, D. et al.

Source: Radiotherapy & Oncology. May2012 Supplement, Vol. 103 Issue s1, pS429-S429. 1p.

SP-0114 ART BY GATING

Authors: Garibaldi, C.

Source: Radiotherapy & Oncology. May2012 Supplement, Vol. 103 Issue s1, pS44-S44. 1p.

362 speaker COMBINING RESEARCH AND CLINICAL WORK WITHOUT A FORMAL PHD PROGRAMME

Authors: Garibaldi, C.

Source: Radiotherapy & Oncology. May2011 Supplement 1, Vol. 99, pS143-S143. 1p.

1243 poster FEASIBILITY STUDY FOR IMAGE-GUIDED PARTIAL BREAST IRRADIATION USING EXACTRAC X-RAY

Authors: Garibaldi, C. Cattani, F. Comi, S. et al.

Source: Radiotherapy & Oncology. May2011 Supplement 1, Vol. 99, pS463-S463. 1p.

REPEAT COMPUTER TOMOGRAPHY IMAGING TO DETECT DOSIMETRIC CHANGES FOR HEAD AND NECK IMRT PLANS

Authors: Garibaldi, C. Rondi, E. Comi, S. et al.

Source: Radiotherapy & Oncology. Aug2009 Supplement, Vol. 92 Issue s1, pS86-S86. 1p.

SP-0464: Commissioning and periodic QA strategies for tracking.

Authors: Garibaldi, C. Russo, S. Comi, S. et al.

Source: Radiotherapy & Oncology. 2014 Supplement, Vol. 111, pS182-S182. 1p.

Subjects: Quality assurance in radiotherapy, Radiotherapy, Cancer research, Medical research, Oncology research, Medical radiology

PO-1783 Leverage radiomic and clinical data in predicting SRS treatment outcomes in patients with brain mets.

Authors: Carloni, G. Marvaso, G. Garibaldi, C. et al.

Source: Radiotherapy & Oncology. 2022 Supplement 1, Vol. 170, pS1590-S1591. 2p.

Subjects: Treatment effectiveness, Forecasting

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions.

Authors: Orecchia, R. Surgo, A. Muto, M. et al.

Source: Ecancermedicalscience. 2016, Vol. 10 Issue 674-708, p1-11. 11p.

Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer.

Authors: Vavassori, A. Jereczek-Fossa, B. A. Zerini, D. et al.

Source: Ecancermedicalscience. 2009, Vol. 3, p1-5. 5p. 2 Black and White Photographs.